An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China
… In response to Dr Yezhao Wang, we refute the suggestion that there was any plagiarism
in our study ─ from concept to analysis to publication. Plagiarism (claiming someone else's …
in our study ─ from concept to analysis to publication. Plagiarism (claiming someone else's …
Viral load of SARS-CoV-2 in clinical samples
…, D Zhang, P Yang, LLM Poon, Q Wang - The Lancet infectious …, 2020 - thelancet.com
An outbreak caused by a novel human coronavirus, severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was first detected in Wuhan in December 2019, 1 and has since …
coronavirus 2 (SARS-CoV-2) was first detected in Wuhan in December 2019, 1 and has since …
Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia
…, Y Liu, DYM Ng, CKC Wan, P Yang, Q Wang… - Clinical …, 2020 - academic.oup.com
Background A novel coronavirus of zoonotic origin (2019-nCoV) has recently been
identified in patients with acute respiratory disease. This virus is genetically similar to SARS …
identified in patients with acute respiratory disease. This virus is genetically similar to SARS …
Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China
…, L Jia, D Huo, B Liu, X Wang, Y Sun, Q Wang… - BMJ global …, 2020 - gh.bmj.com
Introduction Transmission of COVID-19 within families and close contacts accounts for the
majority of epidemic growth. Community mask wearing, hand washing and social distancing …
majority of epidemic growth. Community mask wearing, hand washing and social distancing …
[HTML][HTML] A cluster randomised trial of cloth masks compared with medical masks in healthcare workers
…, AA Chughtai, B Rahman, DE Dwyer, Q Wang - BMJ open, 2015 - bmjopen.bmj.com
Editor9s Note The authors of this article, published in 2015, have written a response to their
work in light of the COVID-19 pandemic. We urge our readers to consider the response …
work in light of the COVID-19 pandemic. We urge our readers to consider the response …
[HTML][HTML] Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis
Y Pan, L Wang, Z Feng, H Xu, F Li, Y Shen, D Zhang… - The lancet, 2023 - thelancet.com
Background Due to the national dynamic zero-COVID strategy in China, there were no
persistent local transmissions of SARS-CoV-2 in Beijing before December, 2022. However, …
persistent local transmissions of SARS-CoV-2 in Beijing before December, 2022. However, …
Potential false-negative nucleic acid testing results for severe acute respiratory syndrome coronavirus 2 from thermal inactivation of samples with low viral loads
…, D Zhang, T Yuan, S Cui, P Yang, Q Wang… - Clinical …, 2020 - academic.oup.com
Background Coronavirus disease-2019 (COVID-19) has spread widely throughout the world
since the end of 2019. Nucleic acid testing (NAT) has played an important role in patient …
since the end of 2019. Nucleic acid testing (NAT) has played an important role in patient …
A cluster randomized clinical trial comparing fit‐tested and non‐fit‐tested N95 respirators to medical masks to prevent respiratory virus infection in health care workers
CR MacIntyre, Q Wang, S Cauchemez… - Influenza and other …, 2011 - Wiley Online Library
Please cite this paper as: MacIntyre et al. (2011) A cluster randomized clinical trial comparing
fit‐tested and non‐fit‐tested N95 respirators to medical masks to prevent respiratory virus …
fit‐tested and non‐fit‐tested N95 respirators to medical masks to prevent respiratory virus …
Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients
X Wang, X Guo, Q Xin, Y Pan, Y Hu, J Li… - Clinical Infectious …, 2020 - academic.oup.com
Background Coronavirus disease 2019 (COVID-19) is a pandemic with no specific antiviral
treatments or vaccines. There is an urgent need for exploring the neutralizing antibodies from …
treatments or vaccines. There is an urgent need for exploring the neutralizing antibodies from …
Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients
X Wang, X Guo, Q Xin, Y Pan, J Li, Y Chu, Y Feng… - MedRxiv, 2020 - medrxiv.org
Background COVID-19 is a pandemic with no specific antiviral treatments or vaccines. The
urgent needs for exploring the neutralizing antibodies from patients with different clinical …
urgent needs for exploring the neutralizing antibodies from patients with different clinical …
